This brand name is authorized in Nigeria.
The drug ESOFAG D contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
N3PA6559FT - ESOMEPRAZOLE
|
|
Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion. |
|
2
|
UNII
5587267Z69 - DOMPERIDONE
|
|
Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-5384 | Capsule | ESOFAG D CAPSULES CAP 30 mg; 40 mg 310 Alu/Alu Strip pack of 10 Capsules | ESOFAG D CAPSULES OMEPRAZOLE 40MG, DOMPERIDONE 30MG SUSTAINED RELEASE ESOMEPRAZOLE 40MG, DOMPERIDONE 30MG. 1.Sugar Spheres 2. Povidone K – 30. 3. Starch. 4.Sucrose. 5.Ethyl Cellulose. 6. Diethyl phthalate. 6. Diethyl phthalate. 7. Sunset Yellow supra. 8. Sunset Yellow Lake B4-5384 Drugs Imported Products 310 Alu/Alu Strip pack of 10 Capsules Prescription Only Medicine (POM) 17/03/2021 MICRO NOVA PHARMACEUTICALS IND. LTD, PLOT 3, BILLINGS WAY, INDUSTRIAL ESTATE, IKEJA IKEJA LAGOS 81299901 solomonsemicrolabs@gmail.com M/S Micro Labs Limited , 92, Sicpot ind. complex Hosur 635 126 India, India | 26/04/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A02BC | Proton pump inhibitors | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-5384 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.